Name: Edwards Lifesciences Corp. (NYSE:EW) | Balance Sheet: Assets (Quarterly)
Creator: Stock Analysis on Net

Balance Sheet: Assets
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

Assets: Selected Items

Download chart

Current Assets: Selected Items

Download chart

Edwards Lifesciences Corp., consolidated balance sheet: assets (quarterly data)

US$ in thousands

	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017
Cash and cash equivalents	862,800)	1,506,900)	1,312,800)	1,174,200)	1,183,200)	1,024,000)	903,500)	662,900)	1,179,100)	1,186,600)	726,800)	709,200)	714,100)	1,261,300)	1,226,400)	1,227,000)	818,300)	630,300)	508,200)	819,300)
Short-term investments	604,000)	287,800)	248,400)	156,400)	219,400)	271,300)	260,300)	368,200)	337,800)	170,300)	207,500)	253,800)	242,400)	334,400)	174,400)	272,300)	519,200)	772,500)	623,600)	98,900)
Accounts receivable, net of allowances	582,200)	600,600)	640,500)	586,600)	514,600)	549,700)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)
Other receivables	82,700)	63,600)	59,800)	77,700)	88,200)	122,000)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)
Accounts and other receivables, net of allowances (legacy)	—)	—)	—)	—)	—)	—)	567,900)	585,100)	599,100)	570,000)	609,600)	578,000)	537,300)	530,100)	520,100)	446,800)	462,200)	475,000)	510,700)	510,200)
Inventories	726,700)	737,800)	759,500)	767,900)	802,300)	773,300)	735,100)	662,200)	640,900)	611,100)	624,900)	630,900)	607,000)	583,800)	568,100)	573,900)	554,900)	538,400)	491,600)	431,400)
Prepaid expenses	85,200)	76,900)	68,600)	77,300)	75,100)	68,600)	57,300)	65,800)	59,100)	57,300)	55,700)	55,400)	54,300)	52,600)	69,900)	78,000)	60,600)	52,800)	54,100)	53,000)
Other current assets	237,100)	241,900)	233,300)	229,100)	208,200)	171,500)	166,200)	163,700)	168,000)	144,400)	130,200)	141,500)	131,800)	150,400)	137,100)	118,900)	116,900)	97,400)	95,200)	105,600)
Current assets	3,180,700)	3,515,500)	3,322,900)	3,069,200)	3,091,000)	2,980,400)	2,690,300)	2,507,900)	2,984,000)	2,739,700)	2,354,700)	2,368,800)	2,286,900)	2,912,600)	2,696,000)	2,716,900)	2,532,100)	2,566,400)	2,283,400)	2,018,400)
Long-term investments	1,834,200)	1,282,000)	1,014,200)	802,200)	801,600)	599,000)	594,400)	587,800)	585,500)	386,000)	412,900)	453,700)	506,300)	479,000)	470,400)	532,100)	567,000)	567,500)	551,500)	519,000)
Property, plant, and equipment, net	1,546,600)	1,464,600)	1,445,800)	1,417,900)	1,395,200)	1,276,300)	1,195,600)	1,100,600)	1,060,300)	973,600)	931,100)	892,200)	867,500)	826,100)	770,200)	711,600)	679,700)	649,600)	627,900)	588,800)
Operating lease right-of-use assets	92,100)	84,800)	84,600)	88,500)	94,200)	89,500)	84,700)	75,500)	80,100)	73,300)	71,200)	69,900)	—)	—)	—)	—)	—)	—)	—)	—)
Goodwill	1,167,900)	1,170,400)	1,171,800)	1,170,800)	1,173,200)	1,170,000)	1,167,700)	1,166,200)	1,167,700)	1,156,600)	1,173,900)	1,103,400)	1,112,200)	1,122,300)	1,118,600)	1,144,800)	1,126,500)	980,500)	965,100)	945,200)
Other intangible assets, net	323,600)	325,300)	327,000)	330,300)	331,400)	332,400)	333,500)	334,800)	336,500)	381,100)	385,600)	341,300)	343,200)	467,900)	466,000)	480,500)	468,000)	414,900)	408,600)	402,100)
Deferred income taxes	246,700)	184,000)	190,500)	209,300)	230,900)	215,200)	204,100)	158,000)	172,200)	155,800)	163,800)	164,500)	174,000)	115,100)	130,100)	181,400)	213,600)	197,100)	185,200)	179,100)
Other assets	110,800)	133,700)	105,300)	125,500)	119,600)	138,000)	153,800)	145,300)	101,800)	100,200)	80,300)	75,500)	33,600)	35,200)	34,800)	57,800)	108,900)	112,400)	116,800)	127,800)
Long-term assets	5,321,900)	4,644,800)	4,339,200)	4,144,500)	4,146,100)	3,820,400)	3,733,800)	3,568,200)	3,504,100)	3,226,600)	3,218,800)	3,100,500)	3,036,800)	3,045,600)	2,990,100)	3,108,200)	3,163,700)	2,922,000)	2,855,100)	2,762,000)
Total assets	8,502,600)	8,160,300)	7,662,100)	7,213,700)	7,237,100)	6,800,800)	6,424,100)	6,076,100)	6,488,100)	5,966,300)	5,573,500)	5,469,300)	5,323,700)	5,958,200)	5,686,100)	5,825,100)	5,695,800)	5,488,400)	5,138,500)	4,780,400)

Total assets exhibited a consistent upward trajectory over the analyzed period, growing from $4.78 billion in March 2017 to $8.50 billion by December 2021. This growth reflects a significant expansion of the balance sheet, with long-term assets contributing more substantially to the overall increase than current assets in the latter half of the period.

Current Asset Dynamics: Current assets grew from $2.02 billion to $3.18 billion, though the growth was characterized by volatility. Cash and cash equivalents showed significant fluctuations, peaking at $1.51 billion in September 2021 before decreasing to $862.8 million by year-end. A notable shift in reporting occurred in September 2020, where legacy receivables were replaced by distinct categories for net accounts receivable and other receivables, maintaining a combined value generally between $500 million and $650 million. Inventories demonstrated a steady increase from $431.4 million in March 2017 to a peak of $802.3 million in December 2020, followed by a slight stabilization around $726.7 million by December 2021.
Long-Term Asset Expansion: Long-term assets nearly doubled, rising from $2.76 billion in March 2017 to $5.32 billion in December 2021. This expansion was primarily driven by two factors: Property, Plant, and Equipment (PP&E), which grew steadily from $588.8 million to $1.55 billion, and long-term investments, which saw an aggressive increase from $519 million in March 2017 to $1.83 billion in December 2021. The latter growth was particularly pronounced during 2021. In contrast, other intangible assets experienced a gradual decline from $402.1 million to $323.6 million, likely attributable to ongoing amortization.
Intangibles and Other Assets: Goodwill remained relatively stable throughout the period, fluctuating slightly between $945.2 million and $1.17 billion, suggesting no major new acquisitions or significant impairments. Operating lease right-of-use assets were introduced in March 2019 and maintained a consistent range between $69.9 million and $92.1 million. Deferred income taxes showed volatility, ending the period at $246.7 million, the highest recorded level since 2018.

The overall asset composition shifted toward non-current assets over time. While current assets provided operational liquidity, the strategic emphasis on PP&E and long-term investments indicates a period of sustained capital expenditure and long-term financial positioning.

AI Ask an analyst for more

My previous chats

Add tokens

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?

Edwards Lifesciences Corp. (NYSE:EW)

Balance Sheet: AssetsQuarterly Data

Assets: Selected Items

Current Assets: Selected Items

Balance Sheet: Assets
Quarterly Data